Treatment of breast cancer by combination therapy
US4775660A · kind A · utility
39Cited by
8References
40Claims
0Family size
Inventors
Key dates
| Filing date | Aug 2, 1984 |
| Grant date | Oct 4, 1988 |
| Priority date | — |
| Expiry date | Aug 2, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of breast cancer in susceptible animals whose ovarian hormonal secretions were previously blocked by surgical or chemical means, e.g., by use of an LH-RH agonist, e.g., [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ]LH-RH ethylamide with a combination therapy comprising administering an antiandrogen, e.g., flutamide and an antiestrogen, e.g., Tamoxifen, pharmaceutical compositions useful for such treatment and two and three component pharmaceutical kits containing such compositions are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.